Sabra Q2 2026 Normalized FFO $0.38; closes $599M YTD investments; reiterates guidance

Sabra Health Care REIT, Inc.

2026-Q2 EPS reported $0.06 revenue$457,619,000

Net loss $(0.10) per share; Normalized FFO $0.38; AFFO $0.39; Normalized AFFO $0.40.
Closed $274.1M in Q2 investments at 8.1% avg initial cash yield; subsequent $223.0M acquisition.
YTD investments total $599.0M at 7.5% avg initial cash yield; additional $100M pipeline expected by year-end.
Same-property managed senior housing Cash NOI up 13.7% YoY; Net Debt/Adjusted EBITDA 4.61x.
Board declared $0.30 quarterly dividend payable Aug 31; full-year 2026 guidance reiterated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.